Goldman Sachs’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.62M | Buy |
605,165
+23,156
| +4% | +$215K | ﹤0.01% | 2716 |
|
|
2025
Q1 | $4.27M | Sell |
582,009
-90,613
| -13% | -$664K | ﹤0.01% | 2867 |
|
|
2024
Q4 | $5.74M | Buy |
672,622
+96,384
| +17% | +$823K | ﹤0.01% | 2751 |
|
|
2024
Q3 | $5.01M | Sell |
576,238
-103,179
| -15% | -$898K | ﹤0.01% | 2755 |
|
|
2024
Q2 | $4.65M | Buy |
679,417
+410,236
| +152% | +$2.81M | ﹤0.01% | 2664 |
|
|
2024
Q1 | $2.45M | Buy |
269,181
+181,628
| +207% | +$1.65M | ﹤0.01% | 3076 |
|
|
2023
Q4 | $390K | Sell |
87,553
-27,833
| -24% | -$124K | ﹤0.01% | 4064 |
|
|
2023
Q3 | $362K | Sell |
115,386
-92,106
| -44% | -$289K | ﹤0.01% | 4025 |
|
|
2023
Q2 | $1.07M | Buy |
207,492
+26,827
| +15% | +$138K | ﹤0.01% | 3575 |
|
|
2023
Q1 | $952K | Sell |
180,665
-1,570
| -0.9% | -$8.27K | ﹤0.01% | 3687 |
|
|
2022
Q4 | $512K | Sell |
182,235
-150,512
| -45% | -$423K | ﹤0.01% | 4076 |
|
|
2022
Q3 | $1.38M | Sell |
332,747
-135,501
| -29% | -$562K | ﹤0.01% | 3632 |
|
|
2022
Q2 | $1.88M | Buy |
468,248
+83,858
| +22% | +$337K | ﹤0.01% | 3497 |
|
|
2022
Q1 | $1.9M | Buy |
384,390
+167,561
| +77% | +$830K | ﹤0.01% | 3632 |
|
|
2021
Q4 | $1.51M | Sell |
216,829
-101,937
| -32% | -$710K | ﹤0.01% | 3703 |
|
|
2021
Q3 | $3.19M | Sell |
318,766
-167,930
| -35% | -$1.68M | ﹤0.01% | 3126 |
|
|
2021
Q2 | $6.9M | Sell |
486,696
-151,053
| -24% | -$2.14M | ﹤0.01% | 2542 |
|
|
2021
Q1 | $10.5M | Buy |
637,749
+132,222
| +26% | +$2.17M | ﹤0.01% | 2173 |
|
|
2020
Q4 | $10.5M | Buy |
505,527
+380,576
| +305% | +$7.88M | ﹤0.01% | 2023 |
|
|
2020
Q3 | $951K | Sell |
124,951
-85,667
| -41% | -$652K | ﹤0.01% | 3341 |
|
|
2020
Q2 | $1.75M | Buy |
210,618
+125,482
| +147% | +$1.04M | ﹤0.01% | 2907 |
|
|
2020
Q1 | $421K | Buy |
85,136
+55,695
| +189% | +$275K | ﹤0.01% | 3575 |
|
|
2019
Q4 | $116K | Sell |
29,441
-18,845
| -39% | -$74.3K | ﹤0.01% | 4110 |
|
|
2019
Q3 | $147K | Buy |
48,286
+14,265
| +42% | +$43.4K | ﹤0.01% | 3996 |
|
|
2019
Q2 | $150K | Sell |
34,021
-22,042
| -39% | -$97.2K | ﹤0.01% | 3938 |
|
|
2019
Q1 | $223K | Sell |
56,063
-28,652
| -34% | -$114K | ﹤0.01% | 3848 |
|
|
2018
Q4 | $337K | Buy |
84,715
+36,308
| +75% | +$144K | ﹤0.01% | 3559 |
|
|
2018
Q3 | $333K | Sell |
48,407
-7,533
| -13% | -$51.8K | ﹤0.01% | 3628 |
|
|
2018
Q2 | $378K | Buy |
55,940
+12,816
| +30% | +$86.6K | ﹤0.01% | 3641 |
|
|
2018
Q1 | $281K | Buy |
43,124
+8,157
| +23% | +$53.2K | ﹤0.01% | 3724 |
|
|
2017
Q4 | $156K | Sell |
34,967
-1,792
| -5% | -$8K | ﹤0.01% | 3875 |
|
|
2017
Q3 | $227K | Buy |
36,759
+3,342
| +10% | +$20.6K | ﹤0.01% | 3839 |
|
|
2017
Q2 | $310K | Buy |
33,417
+1,422
| +4% | +$13.2K | ﹤0.01% | 3778 |
|
|
2017
Q1 | $297K | Sell |
31,995
-17,903
| -36% | -$166K | ﹤0.01% | 3785 |
|
|
2016
Q4 | $418K | Sell |
49,898
-22,285
| -31% | -$187K | ﹤0.01% | 3551 |
|
|
2016
Q3 | $496K | Buy |
72,183
+24,369
| +51% | +$167K | ﹤0.01% | 3440 |
|
|
2016
Q2 | $237K | Buy |
+47,814
| New | +$237K | ﹤0.01% | 3764 |
|
|
2015
Q3 | – | Sell |
-12,993
| Closed | -$273K | – | 4663 |
|
|
2015
Q2 | $273K | Buy |
+12,993
| New | +$273K | ﹤0.01% | 3786 |
|